Chee Khoon Lee, P., Bin-Chi Liao, M., Shalini Subramaniam, M., Chao-Hua Chiu, M., Antony J. Mersiades, M., Chao-Chi Ho, M., . . . James Chih-Hsin Yang, M. Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation–Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE). Elsevier.
Chicago Style (17th ed.) CitationChee Khoon Lee, PhD, et al. Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation–Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE). Elsevier.
MLA (9th ed.) CitationChee Khoon Lee, PhD, et al. Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation–Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE). Elsevier.
Warning: These citations may not always be 100% accurate.